Document is current
Any future updates will be listed below
-
Authors
Burmester, Gerd R
Kaeley, Gurjit S
Kavanaugh, Arthur F
Gabay, Cem
MacCarter, Daryl K
Nash, Peter
Takeuchi, Tsutomu
Goss, Sandra L
Rodila, Ramona
Chen, Kun
Kupper, Hartmut
Kalabic, Jasmina
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct01185288 at ClinicalTrials.govnct01185301 at ClinicalTrials.govDocuments that mention this clinical trial
Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis
https://doi.org/10.1136/annrheumdis-2016-209322
Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab (Pre-results)
https://doi.org/10.1136/rmdopen-2017-000465
nct01185301 at ClinicalTrials.govDocuments that mention this clinical trial
Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis
https://doi.org/10.1136/annrheumdis-2016-209322
Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial
https://doi.org/10.1136/annrheumdis-2013-204769
Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab (Pre-results)
https://doi.org/10.1136/rmdopen-2017-000465
nct01185288 at ClinicalTrials.govDocuments that mention this clinical trial
Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis
https://doi.org/10.1136/annrheumdis-2016-209322
Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial
https://doi.org/10.1136/annrheumdis-2013-204769
Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab (Pre-results)
https://doi.org/10.1136/rmdopen-2017-000465
nct01185301 at ClinicalTrials.govDocuments that mention this clinical trial
Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis
https://doi.org/10.1136/annrheumdis-2016-209322
Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab (Pre-results)
https://doi.org/10.1136/rmdopen-2017-000465
nct01185288 at ClinicalTrials.govDocuments that mention this clinical trial
Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis
https://doi.org/10.1136/annrheumdis-2016-209322
Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial
https://doi.org/10.1136/annrheumdis-2013-204769
Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab (Pre-results)
https://doi.org/10.1136/rmdopen-2017-000465
Documents that mention this clinical trial
Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis
https://doi.org/10.1136/annrheumdis-2016-209322
Treatment efficacy and methotrexate-related toxicity in patients with rheumatoid arthritis receiving methotrexate in combination with adalimumab (Pre-results)
https://doi.org/10.1136/rmdopen-2017-000465
-
Funding
Funding for this research was provided by:
AbbVie, Inc.
